Philadelphia, Pennsylvania, United States The main office of represented VC is situated in the Philadelphia. The company was established in North America in United States.
The usual cause for the fund is to invest in rounds with 8-9 partakers. Despite the Druid BioVentures, startups are often financed by PathoCapital, Latterell Venture Partners, Genesys Capital. The meaningful sponsors for the fund in investment in the same round are PathoCapital, Latterell Venture Partners, Genesys Capital. In the next rounds fund is usually obtained by Savitr Capital, PathoCapital, Latterell Venture Partners.
The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2012. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2015. This Druid BioVentures works on 4 percentage points more the average amount of lead investments comparing to the other organizations.
Among the most popular portfolio startups of the fund, we may highlight Naurex. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Therapeutics, Biotechnology.
The overall number of key employees were 1.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Anhui Hongye Guanli | Anhui, China, Hefei |
| Citi Singapore | Central, Central Region, Singapore |
| CoinUs | - |
| Equity 38 | Atlanta, Georgia, United States |
| Hangzhou Economic Development Zone Capital | China, Hangzhou, Zhejiang |
| Lasa Juhuitong Zichan Guanli | Chengguan District, China, Lhasa |
| Martin Global AG | Buchs, Inner-Rhoden, Switzerland |
| RimAsia Capital Partners | China, Hong Kong, Hong Kong Island |
| Tamiami Angel Funds | Florida, Naples, United States |
| UDC Ventures | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Naurex | $80M | 03 Dec 2014 | Illinois, United States | ||
Naurex | $38M | 17 Dec 2012 | Illinois, United States | ||
Naurex | $18M | 11 May 2011 | Illinois, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Naurex | $80M | 03 Dec 2014 | Illinois, United States | ||
Naurex | $38M | 17 Dec 2012 | Illinois, United States | ||
Naurex | $18M | 11 May 2011 | Illinois, United States |
